- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Chimeric Antigen Receptor T-cells
Total 2316 results
-
Shanghai Ming Ju Biotechnology Co., Ltd.CompletedDiffuse Large B Cell LymphomaChina
-
Chembrain LTDUniversity of Oulu; Jyväskylä Central Hospital; Apollo Hospital, New Delhi, IndiaActive, not recruitingGlioblastoma | Glioblastoma Multiforme | Glioma, MalignantFinland, India
-
Shenzhen Pregene Biopharma Co., Ltd.Recruiting
-
Peking UniversityCARsgen Therapeutics Co., Ltd.Completed
-
Lazaros LekakisGenentech, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Aggressive Non-Hodgkin LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationRecruitingDiffuse Large B Cell LymphomaUnited States
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Second Affiliated Hospital of Suzhou UniversityUnknownFollicular Lymphoma | Mantle Cell Lymphoma | B Acute Lymphoblastic LeukemiaChina
-
Sun Yat-sen UniversityUnknownNasopharyngeal CarcinomaChina
-
Fundacion Clinic per a la Recerca BiomedicaNot yet recruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaSpain
-
Baylor College of MedicineCancer Prevention Research Institute of Texas; The Methodist Hospital Research... and other collaboratorsRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Active, not recruitingLeukemia, Lymphoblastic (Acute)United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Recurrent Mantle Cell Lymphoma | Metastatic Lung Non-Small Cell Carcinoma | Refractory Chronic Lymphocytic Leukemia | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Acute Lymphoblastic Leukemia | Metastatic Triple-Negative... and other conditionsUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruiting
-
National Cancer Institute (NCI)CompletedMyeloma-Multiple | Myeloma, Plasma-CellUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnProgressive Disease | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Minimal Residual Disease | Recurrent Chronic Lymphocytic Leukemia | CD19 Positive | CD22...United States
-
Nationwide Children's HospitalNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | B Cell Leukemia | B-cell Non Hodgkin Lymphoma | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Acute Lymphoblastic Leukemia With Failed RemissionUnited States
-
Zhejiang UniversityRecruitingRefractory Metastatic Colorectal CancerChina
-
National Cancer Institute (NCI)Active, not recruitingMyeloma-Multiple | Myeloma, Plasma-CellUnited States
-
Cellular Biomedicine Group Ltd.Shanghai Zhongshan HospitalUnknownHepatocellular CarcinomaChina
-
University College, LondonCompletedDiffuse Large B-Cell LymphomaUnited Kingdom
-
Children's National Research InstituteRecruitingSolid TumorUnited States
-
Shenzhen Geno-Immune Medical InstituteShenzhen Children's Hospital; Shenzhen Hospital of Southern Medical UniversityUnknown
-
Zhejiang UniversityRecruiting
-
University of PennsylvaniaCompletedSubjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA)United States
-
Tongji UniversityUnknown
-
Peking UniversityShanghai Ming Ju Biotechnology Co., Ltd.RecruitingAdvanced Solid TumorChina
-
Shenzhen Geno-Immune Medical InstituteRecruitingT-Cell Acute Lymphoblastic LeukemiaChina
-
Second Military Medical UniversityUnknownRecurrent B-Cell Tumor | Refractory B-Cell TumorChina
-
Henan Cancer HospitalThe Beijing Pregene Science and Technology Company, Ltd.UnknownB-cell Acute Lymphoblastic LeukemiaChina
-
Mari DallasRecruitingAllogeneic Hematopoietic Stem Cell TransplantationUnited States
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Yanda Ludaopei HospitalRecruitingCD19+ and CD 22+ B-ALLChina
-
Bioray LaboratoriesChanghai HospitalSuspendedCastrate-Resistant Prostate CancerChina
-
Shenzhen Geno-Immune Medical InstituteRecruitingB-Cell Acute Lymphoblastic LeukemiaChina
-
Corcept TherapeuticsCompletedHealthy AdultsNetherlands
-
Shanghai Ming Ju Biotechnology Co., Ltd.RecruitingAcute Lymphocytic LeukemiaChina
-
The First Affiliated Hospital of Soochow UniversityWest China Hospital; Affiliated Hospital of Jiangnan University; The Affiliated... and other collaboratorsRecruitingRelapsed/Refractory B-cell Non-Hodgkin's LymphomaChina
-
National University Hospital, SingaporeNot yet recruitingOther Solid Tumors | HER2+ Advanced Breast Cancer
-
Children's National Research InstituteActive, not recruitingMedulloblastoma, Childhood | Embryonal Tumor With Multilayered Rosettes | Pineoblastoma | Embryonal Tumor of CNS | Atypical Teratoid/Rhabdoid Tumor of CNSUnited States
-
TC BiopharmNot yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes
-
National Cancer Institute (NCI)CompletedLeukemia | B Cell Lymphoma | Non-Hodgkin Lymphoma | ALL | Large Cell LymphomaUnited States
-
Mitchell Horwitz, MDCompletedHematological MalignanciesUnited States
-
The Affiliated Hospital of Xuzhou Medical UniversityXuzhou Medical University; IIT MediTech Co. LtdRecruiting
-
Laura JohnstonNational Institutes of Health (NIH)CompletedGraft Versus Host Disease | Allogeneic Hematopoietic Cell Transplant RecipientUnited States
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompleted
-
Beijing Tsinghua Chang Gung HospitalBeijing DCTY® Biotech Co.,Ltd.Not yet recruiting
-
National Cancer Institute (NCI)CompletedLymphoma, Large B-Cell, Diffuse | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, Anaplastic | Lymphoma, Extranodal NK-T-Cell | Enteropathy-Associated T-Cell LymphomaUnited States
-
Chinese PLA General HospitalRecruitingNon-hodgkin Lymphoma,B CellChina
-
UNC Lineberger Comprehensive Cancer CenterNational Institutes of Health (NIH)RecruitingEpithelial Ovarian CancerUnited States
-
National Cancer Institute (NCI)CompletedT Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell MalignanciesLymphoma, B-Cell | Lymphoma, Non-hodgkinsUnited States
-
Beijing GoBroad HospitalNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | Refractory Acute Lymphoblastic Leukemia | T-Cell Acute Lymphocytic Leukemia